The report highlights Boston Scientific's progress in 2023 toward their environmental, social, and governance (ESG) goals. The company launched nearly 90 products, expanded their digital and operational capabilities, and accelerated research and development (R&D). They achieved 82% renewable electricity, bringing them closer to their goal of 100% by the end of 2024, and further defined their path to net-zero greenhouse gas emissions across their value chain by 2050. Boston Scientific also donated more than $76 million to fund global medical research, fellowships, education, and charitable organizations. The company helped improve the lives of more than 37 million patients around the world.
Meet us at the 85th Annual Meeting of the Academy of Management (AOM 2025) in Copenhagen!